These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5923599)

  • 1. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):581-92. PubMed ID: 5923599
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 3. o,p'DDD therapy in invasive adrenocortical carcinoma.
    Becker D; Schumacher OP
    Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of adrenocortical cancer treated with O,P'-DDD.
    Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M
    Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal cortical carcinoma. Clinical features of 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):572-80. PubMed ID: 5923598
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency.
    Temple TE; Jones DJ; Liddle GW; Dexter RN
    N Engl J Med; 1969 Oct; 281(15):801-5. PubMed ID: 4309238
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
    Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
    J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
    Helson L; Wollner N; Murphy ML; Schwartz MK
    Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical application of o.p' DDD to the case of adrenal cortex cancer].
    Naruse T; Sasaki T; Yamaoka T; Matsuoka K; Nekita H
    Horumon To Rinsho; 1970 Mar; 18(3):241-4. PubMed ID: 5464572
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD.
    Gustafsson JA; Lisboa BP
    Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms].
    Perevodchikova NI; Platinskiĭ LV; Kertsman VI
    Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074
    [No Abstract]   [Full Text] [Related]  

  • 13. Testosterone and androstenedione production rates in patients with metastatic adrenal cortical carcinoma.
    Bardin CW; Lipsett MB; French AM
    J Clin Endocrinol Metab; 1968 Feb; 28(2):215-20. PubMed ID: 5636152
    [No Abstract]   [Full Text] [Related]  

  • 14. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of adrenocortical steroid production in therapy].
    Bricaire H; Philbert M; Luton JP
    Rev Fr Etud Clin Biol; 1968; 13(6):563-7. PubMed ID: 4178146
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.
    Faggiano A; Leboulleux S; Young J; Schlumberger M; Baudin E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):110-3. PubMed ID: 16402938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of virilizing adrenocortical carcinoma. Treatment with Op'DDD].
    Roussel J; Hartemann P; Schoumacher P; Metz R; Leclere J; Kessler Y
    Ann Med Nancy; 1965 Nov; 4():971-7. PubMed ID: 5852075
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion of virilization to feminization in a young girl with adrenal cortical carcinoma.
    Halmi KA; Lascari AD
    Cancer; 1971 Apr; 27(4):931-5. PubMed ID: 5574080
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of adrenocortical carcinoma with o,p'-DDD.
    Hoffman DL; Mattox VR
    Med Clin North Am; 1972 Jul; 56(4):999-1012. PubMed ID: 5034421
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone-secreting tumors of the adrenal cortex in children.
    Hayles AB; Hahn HB; Sprague RG; Bahn RC; Priestley JT
    Pediatrics; 1966 Jan; 37(1):19-25. PubMed ID: 4285417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.